Literature DB >> 2206112

Is it time to measure apolipoprotein B?

A D Sniderman1, J Silberberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2206112     DOI： 10.1161/01.atv.10.5.665

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN： 0276-5047


× No keyword cloud information.
  5 in total

Review 1.  Apolipoproteins and risk of coronary heart disease.

Authors:  P W Connelly
Journal:  CMAJ       Date:  1991-05-15       Impact factor: 8.262

2.  What should be done about asymptomatic hypercholesterolaemia?

Authors:  G R Thompson
Journal:  BMJ       Date:  1991-03-16

3.  Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy.

Authors:  William Insull; Peter P Toth; H Robert Superko; Roopal B Thakkar; Scott Krause; Ping Jiang; Rhea A Parreno; Robert J Padley
Journal:  Vasc Health Risk Manag       Date:  2010-11-24

4.  Hypercholesterolemia and apolipoprotein B expression: regulation by selenium status.

Authors:  Sanjiv Dhingra; Mohinder P Bansal
Journal:  Lipids Health Dis       Date:  2005-11-05       Impact factor: 3.876

5.  Central adiposity and atherogenic lipids in Saudi diabetics.

Authors:  S Khandekar; S A Noeman; K Muralidhar; M Gadallah; K S Al-Sawaf
Journal:  Ann Saudi Med       Date:  1994-07       Impact factor: 1.526
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.